logo

LH

Labcorp·NYSE
--
--(--)
--
--(--)
7.74 / 10
Outperform

LH’s fundamental analysis yields an outstanding rating, driven by strong cash-MV and net cash flow from operating activities per share YoY growth. However, basic and diluted earnings per share growth are noted as headwinds, placing the overall fundamental score at 7.7/10 and the rating at ‘Outperform’. This indicates healthy financial strength but highlights some pressure on profitability metrics.

Fundamental(7.74)SentimentTechnical

Analysis Checks(5/10)

Revenue-MV
Value0.52
Score3/3
Weight40.57%
1M Return9.68%
Net cash flow from operating activities per share (YoY growth rate %)
Value27.99
Score3/3
Weight19.90%
1M Return5.16%
Net income-Revenue
Value-0.33
Score2/3
Weight9.25%
1M Return2.86%
Basic earnings per share (YoY growth rate %)
Value19.11
Score1/3
Weight2.09%
1M Return0.58%
Total profit (YoY growth rate %)
Value18.20
Score1/3
Weight5.59%
1M Return1.57%
Net cash flow from operating activities (YoY growth rate %)
Value26.92
Score3/3
Weight20.36%
1M Return5.21%
Diluted earnings per share (YoY growth rate %)
Value18.93
Score1/3
Weight1.94%
1M Return0.52%
Asset-MV
Value-0.50
Score0/3
Weight-15.80%
1M Return-3.95%
Net profit attributable to parent company shareholders (YoY growth rate %)
Value18.12
Score1/3
Weight7.71%
1M Return2.16%
Cash-MV
Value-0.20
Score2/3
Weight8.38%
1M Return2.59%
Is LH undervalued or overvalued?
  • LH scores 7.74/10 on fundamentals and holds a Discounted valuation at present. Backed by its 8.48% ROE, 6.22% net margin, 26.87 P/E ratio, 2.64 P/B ratio, and 93.22% earnings growth, these metrics solidify its Outperform investment rating.